These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 4564745)
1. Report on a double-blind investigation into the influence of -pyridyl-carbinol on the cholesterol level of the blood. Nelemans FA Arzneimittelforschung; 1972 Aug; 22(8):1410-3. PubMed ID: 4564745 [No Abstract] [Full Text] [Related]
2. Biphenabid (Probucol): a new hypocholesterolemic agent. Kalams Z; Dacquisto M; Kornett GS Curr Ther Res Clin Exp; 1971 Nov; 13(11):692-4. PubMed ID: 5000716 [No Abstract] [Full Text] [Related]
3. [Clinical evaluation of the therapeutic activity of the -pyridyl-carbinol ester of clofibric acid]. Silingardi V; Renzi R; Mora A; Di Prisco AU Minerva Med; 1973 Mar; 64(16):751-69. PubMed ID: 4704721 [No Abstract] [Full Text] [Related]
5. Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial. Bokura H; Kobayashi S Eur J Clin Nutr; 2003 May; 57(5):721-5. PubMed ID: 12771974 [TBL] [Abstract][Full Text] [Related]
6. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia. Miller NE; Clifton-Bligh P; Nestel PJ; Whyte HM Med J Aust; 1973 Jun; 1(25):1223-7. PubMed ID: 4579666 [No Abstract] [Full Text] [Related]
8. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials. Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168 [TBL] [Abstract][Full Text] [Related]
10. [The cholesterol question. Disinformed information]. Bobbio M; Brusca A G Ital Cardiol; 1991 Sep; 21(9):1029-33. PubMed ID: 1790828 [No Abstract] [Full Text] [Related]
11. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E; Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231 [TBL] [Abstract][Full Text] [Related]
12. [Risk patients are often insufficiently treated. LDL cholesterol to be held down even more vigorously]. MMW Fortschr Med; 2004 Oct; 146(44):56-7. PubMed ID: 15566253 [No Abstract] [Full Text] [Related]
13. [Effect of parachlorophenoxyisobutyric acid (CPIB acid) and of diet on blood cholesterol and on the beta-alpha lipoprotein ratio in aged subjects]. Bronzini A; Di Gregorio D; Scotti G G Gerontol; 1969 Nov; 17(11):1067-75. PubMed ID: 5397791 [No Abstract] [Full Text] [Related]
14. Practical possibilities for lowering serum cholesterol. Results of a double-blind study. Nelemans FA Nutr Metab; 1973; 15(1):151-3. PubMed ID: 4576165 [No Abstract] [Full Text] [Related]
15. A statin in every medicine cabinet? Walsh MN Health News; 2002 Sep; 8(9):3. PubMed ID: 12229899 [No Abstract] [Full Text] [Related]
16. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption. Bruckert E; Giral P; Tellier P Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406 [No Abstract] [Full Text] [Related]
18. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men. Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E; J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343 [TBL] [Abstract][Full Text] [Related]